

Genoseq Diagnostics Email Formats
Contact top employees from
Genoseq Diagnostics
- Genoseq Diagnostics uses 6 different email formats. The most common is lastNameInitial-firstNameInitial (for example, d-j@genoseqdx.com), which appears in about 42% of work addresses.
- Other common patterns include:
- lastName-firstName: doe-jane@genoseqdx.com (10%)
- lastNameInitial-firstName: d-jane@genoseqdx.com (29%)
Genoseq Diagnostics’s Popular Email Formats
| Format | Example | Percentage |
|---|---|---|
Format lastNameInitial-firstNameInitial | Percentage: 42% | |
Format lastNameInitial-firstName | Percentage: 29% | |
Format lastName-firstName | Percentage: 10% | |
Format lastNameInitialfirstName | Percentage: 9% | |
Format lastNamefirstNameInitial | Percentage: 7% | |
Format firstName-lastNameInitial | Percentage: 3% |
Contact top employees from
Genoseq Diagnostics
0% completed
Verify Genoseq Diagnostics Business Emails
Genoseq Diagnostics employee email verification for instant deliverability checks.Companies Similar to Genoseq Diagnostics
Genoseq Diagnostics Corporate Information: FAQ
The company currently specializes in the Biotechnology area. The annual revenue of Genoseq Diagnostics varies between 1 and 10M. To connect with Genoseq Diagnostics employee register on SignalHire.
Genoseq Diagnostics uses 6 email formats across its organization. The most common pattern is lastNameInitial-firstNameInitial (e.g., d-j@genoseqdx.com), used in approximately 42% of work addresses.
Genoseq Diagnostics currently employs over 10-50 people from India, with a head office in Chennai, Tamilnadu.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.




